ClinicalTrials.gov
ClinicalTrials.gov Menu

Occupational Health Hazards Among Flour Mills Workers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03678519
Recruitment Status : Not yet recruiting
First Posted : September 19, 2018
Last Update Posted : September 19, 2018
Sponsor:
Information provided by (Responsible Party):
Ayah Atef Alkarn, Assiut University

Brief Summary:
Flour milling is from the oldest trade industry. Several problems arise during functioning and maintenance operations. Production process involves the breakdown of grains to separate their outer covering and inner endosperm grinding to fine flour particles. Workers are at substantial risk with two main problems causing severe health issues and accidents. The first is the improper flour milling process including intake and final products collection systems. The second is the unawareness and unavailability of PPE.

Condition or disease Intervention/treatment
Occupational Exposure Diagnostic Test: Pulmonary function test

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Occupational Health Hazards Among Flour Mills Workers And Effect Of Smoking Cessation Program On Smokers, Assiut
Estimated Study Start Date : December 2018
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Exposed workers
Flour mills workers exposed to health hazards
Diagnostic Test: Pulmonary function test
Pulmonary Function tests using Spirometry. It will show following indices of ventilatory functions: Forced vital capacity (FVC), Forced expiratory volume in the 1st second (FEV1) and Forced expiratory volume in the 1st second as a percentage of the Forced vital capacity (FEV1/FVC %).




Primary Outcome Measures :
  1. Detect number of workers who have occupational diseases [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Number of patients who have declined pulmonary function tests [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Flour Mills Workers, Assiut
Criteria
Workers in flour mills

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03678519


Contacts
Contact: Hussein H Zayet, Professor 01063885982 drzayet@yaho..com
Contact: Shimaa A Mohammed, M.D 01000525137 Shima_dola@yahoo.com

Locations
Egypt
Assiut University Not yet recruiting
Assiut, Egypt, 71111
Contact: Ayah Atef Alkarn    01093509890    ayahatefalkarn@yahoo.com   
Sponsors and Collaborators
Assiut University

Publications:

Responsible Party: Ayah Atef Alkarn, Principal investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03678519     History of Changes
Other Study ID Numbers: OHHFM
First Posted: September 19, 2018    Key Record Dates
Last Update Posted: September 19, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No